Literature DB >> 11792226

Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction.

John A. Ambrose1, Zaheed Tai.   

Abstract

In the last 20 years there have been enormous advances in our understanding of the acute coronary syndromes and how to manage patients presenting with them. In the 1980s, we began to understand the importance of thrombus formation was in the pathophysiology of acute coronary syndromes. Randomized studies also showed that appropriate antithrombotic therapy reduced the subsequent occurrence of myocardial infarction and death. In the 1990s, other therapeutic modalities and particularly percutaneous coronary intervention have come to the forefront as effective therapy in these syndromes. The glycoprotein IIb/IIIa receptor antagonists along with coronary stent implantation have proved extremely beneficial in short- and long-term management. We also have learned the importance of risk-factor modification in preventing subsequent events. In the future, greater efforts will focus on primary prevention.

Entities:  

Year:  2002        PMID: 11792226     DOI: 10.1007/s11936-002-0024-2

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  47 in total

1.  Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes.

Authors:  K Mizuno; K Satomura; A Miyamoto; K Arakawa; T Shibuya; T Arai; A Kurita; H Nakamura; J A Ambrose
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

Review 2.  Low-molecular-weight heparins.

Authors:  J I Weitz
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  Unstable angina. A classification.

Authors:  E Braunwald
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

5.  Anatomic-physiologic links between acute coronary syndromes.

Authors:  R Gorlin; V Fuster; J A Ambrose
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

6.  Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators.

Authors: 
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

7.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

Review 8.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.

Authors:  A Farb; A P Burke; A L Tang; T Y Liang; P Mannan; J Smialek; R Virmani
Journal:  Circulation       Date:  1996-04-01       Impact factor: 29.690

9.  Comparison of coronary angiographic findings during the first six hours of non-Q-wave and Q-wave myocardial infarction.

Authors:  W D Keen; M P Savage; D L Fischman; A Zalewski; P Walinsky; D Nardone; S Goldberg
Journal:  Am J Cardiol       Date:  1994-08-15       Impact factor: 2.778

10.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

Authors: 
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.